tiprankstipranks
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market

PTC Therapeutics (PTCT) Income Statement

Compare
348 Followers

PTC Therapeutics Income Statement

Last quarter (Q3 2024), PTC Therapeutics's total revenue was $196.79M, an increase of 0.11% from the same quarter last year. In Q3, PTC Therapeutics's net income was $-106.65M. See PTC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 937.82M$ 698.80M$ 538.59M$ 380.77M$ 306.98M
Gross Profit
$ 872.34M$ 654.12M$ 506.26M$ 361.82M$ 294.85M
Operating Expenses
$ 1.31B$ 1.09B$ 881.21M$ 759.70M$ 487.64M
Depreciation and Amortization
$ 236.59M$ 128.84M$ 71.52M$ 49.58M$ 36.06M
EBITDA
$ -330.34M$ -367.78M$ -374.44M$ -297.00M$ -191.38M
Operating Income
$ -349.40M$ -439.93M$ -374.94M$ -397.88M$ -192.80M
Other Income/Expenses
$ -346.71M$ -147.56M$ -143.40M$ -59.36M$ -47.13M
Pretax Income
$ -696.11M$ -587.49M$ -518.34M$ -402.93M$ -239.93M
Net Income
$ -626.60M$ -559.02M$ -523.90M$ -438.16M$ -251.58M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -8.37$ -7.79$ -7.43$ -6.64$ -4.27
Diluted EPS
$ -8.37$ -7.79$ -7.43$ -6.64$ -4.27
Weighted Average Shares Outstanding
74.84M 71.73M 70.47M 66.03M 58.86M
Weighted Average Shares Outstanding (Diluted)
74.84M 71.73M 70.47M 66.03M 58.86M
Currency in USD

PTC Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis